IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q2 2016 Holdings

Filed 2016-08-12 | 15 holdings | $12.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adaptimmune Therapeutics plc(ADAPY)SPONSORED ADR00653A107$8.6M1,054,86468.9%
Ardelyx, Inc.(ARDX)COM039697107$3.7M428,98930.0%
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$42.9K3,967,9000.3%
Universal American Corp.COM91338E101$21.3K2,814,8830.2%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$17.2K975,2850.1%
Alder Biopharmaceuticals Inc.(ALDR1EUR)COM014339105$15.0K600,9290.1%
Epizyme, Inc.(EPZMEUR)COM29428V104$12.2K1,191,9950.1%
NanoString Technologies, Inc.(NSTGEUR)COM63009R109$9.2K727,8570.1%
Zafgen, Inc.COM98885E103$4.6K760,0460.0%
Nexvet Biopharma public limited companyORD SHSG6503X109$4.2K900,1550.0%
Orexigen Therapeutics, Inc.COM686164104$2.3K5,427,5590.0%
Acceleron Pharma Inc.(XLRN)COM00434H108$1.7K48,8390.0%
NeuroDerm Ltd.ORD SHSM74231107$1.4K83,2110.0%
Regenxbio Inc.(RGNX)COM75901B107$1.3K156,7410.0%
BioDelivery Sciences International, Inc.(BDSIUSD)COM09060J106$791335,2390.0%